Capsule Technology Group
Executive Summary
Windsor, Ontario-based firm will produce EPA-CHOL 700, an EPA/DHA concentrate product for reducing cholesterol at its newly built Mulgrave, Nova Scotia plant. The $ 8 mil. plant was constructed with the help of tax breaks and an interest-free loan from the Canadian government. Wyeth-Canada will market the product in that country pending Canadian marketing approval, Capsule Technology says, estimating sales of $ 13 mil. over the next 12 months.